Participated · Equity · Nov 2024

TailorMed provides an enterprise platform that manages the full lifecycle of patient support programs to reduce cost barriers and improve medication access and adherence. The company has built the nation’s largest Affordability Network, deployed across more than 800 hospitals, 1,300 clinics, and 650 pharmacies. TailorMed integrates directly with manufacturer assistance programs to automate patient support and streamline stakeholder workflows. Having reached an inflection point in its network evolution, the company is expanding into an end-to-end platform to tackle cost, access, and adherence across the medication continuum. The new financing will fund that expansion and broader efforts to create a seamless flow of data and resources across patients, providers, pharmacies, life sciences, and payers. TailorMed frames this work as addressing affordability at the point a prescription is written or dispensed to prevent delayed or skipped treatments. TailorMed Medical provides a technology platform that automates identification of financially at-risk patients and matches and enrolls them in financial resources such as co-pay assistance, replacement drug programs, government subsidies, community and state resources, disease-specific foundations, and programs addressing living expenses. Its platform is designed to reduce out-of-pocket responsibility for patients, helping to eliminate downstream financial hardship and avoidance of care. For health organizations, TailorMed shifts financial assistance from reactive matching or downstream collections to a proactive, point-of-care approach. The company serves physician practices, specialty clinics and health systems, and in 2021 expanded adoption into pharmacies nationwide. TailorMed said it will use the new funding to further expand its reach across health care with innovative financial solutions. Srulik Dvorsky is CEO and co-founder and the company is based in New York City.

Participated · Series A · Mar 2023

OpenLoop is a Des Moines-based white-label telehealth support services provider that offers a comprehensive nationwide payer coverage network and end-to-end virtual care from first visit to final payment. Its API-driven, HIPAA-compliant platform can be customized to client brands and securely houses patient PII. The platform enables clinicians to manage appointments, write prescriptions, chart notes, and handle booking and payments in a single system. OpenLoop's network spans all 50 states with 6,000+ certified clinicians, covers 30+ digital health specialties and supports 15 languages. In the last year the network reached 10,000 providers, the company signed over 80 new clients, and internal headcount increased by 640%. The company is led by CEO Jon Lensing and intends to use the new funding to accelerate growth and expand operations. OpenLoop provides end-to-end clinical and operational support to companies launching and scaling virtual care across all 50 states. Its offerings include regulatory and legal setup, clinician staffing, a whitelabeled telehealth technology platform, practice management, and revenue cycle management. The company positions itself as a plug‑and‑play partner that handles credentialing, compliance, EHR access, billing, and administrative functions to accelerate go‑to‑market for virtual care providers. Leadership is led by CEO Jon Lensing and COO Christian Williams. OpenLoop plans to use the new funding to advance its initiative supporting virtual care launches, double headcount, and expand its practice management and revenue cycle management arms. The raise brings the company additional runway to scale national operations and broaden service capacity. OpenLoop operates a digital marketplace that matches fully-vetted clinicians to telehealth shifts and rural healthcare needs. Founded by Dr. Jon Lensing and Christian Williams and first launched in March 2020, the platform accelerated delivery of patient care by connecting clinicians and insurance partners with telehealth companies. The company grew its fractional clinician workforce to over 5,500 clinicians within the first ten months of operation and currently services 42,000 ZIP codes. Clients include Vermeer Corporation, Cano Health, and several telemedicine brands expanding patient visit capacity nationally. OpenLoop plans to use the newly raised capital to expedite development of its marketplace technology and to grow its team of experts. The company is Techstars-backed and operates a network of clinicians and telehealth providers.

Participated · Series A · Dec 2022

Cardiosense develops a physiological waveform AI platform, novel digital tools, multi-sensor devices, and analysis algorithms to detect early signs of cardiovascular disease and inform personalized therapy. Its clinical application focuses on improving management of congestive heart failure (CHF). The company intends to use new funding to expand its team, accelerate product development, and support an expansive heart failure study. Cardiosense highlights the large CHF burden—more than 6 million people in the U.S. and projected healthcare costs exceeding $70 billion annually by 2030. Led by CEO Amit Gupta and based in Chicago, the company positions its technology to improve patient outcomes and therapy management.

Led · Series A · Apr 2022

Pathware develops integrated hardware and software to bring digital pathology from the central laboratory to the point-of-care. The company's core product pairs imaging hardware with software to enable decentralized pathology workflows. Pathware intends to use its newly raised funds to expand the team and to submit its integrated hardware and software system to the FDA for clearance. The company announced a $7M Series A to support these efforts. Pathware is led by newly named CEO TJ Meyer, who previously led global marketing, strategy, clinical support, and business development at Veran Medical Technologies. During his tenure at Veran, the company grew revenues from $2 million to $30 million and was acquired by Olympus in December 2020.

Participated · Series A · Dec 2021

Prolucent builds an AI-powered workforce management platform that unifies staffing across permanent, part-time, per diem, and travel staff. Its LiquidCompass VMS+ platform offers vendor-neutral management of staffing orders, fulfillment, credentialing, invoicing and advanced analytics. The platform includes a talent marketplace, digital front door, and real-time workforce intelligence tools to help health systems reduce labor costs and improve operational efficiency. Prolucent’s technology is integrated with Northwell Health’s FlexStaff internal staffing agency and external contract agencies. The platform is currently deployed across Northwell’s 21 hospitals in the greater New York metro area and beyond. Prolucent plans to use the strategic investment to accelerate development and expand its AI-driven workforce management solutions to healthcare organizations nationwide. Prolucent develops enterprise-wide healthcare workforce optimization software and services, centered on its Liquid Compass workforce management platform. The AI-driven Liquid Compass integrates a talent marketplace, advanced analytics, and a vendor-neutral VMS to centralize management of core staff, flexible staff, and external contingent staff. The platform aims to improve recruitment, utilization, and labor cost management to create sustainable labor cost savings for healthcare providers. With labor expenses accounting for more than 50 percent of hospitals' total expenses, Prolucent positions its solutions as a means to improve operating margins and workforce balance. The company said the new capital will fuel continued product innovation and support nationwide expansion as it embarks on its next phase of growth. Prolucent is based in Dallas. Prolucent Health offers end-to-end workforce optimization solutions for healthcare organizations, powered by its talent engagement platform Liquid Compass®. The platform uses technology, artificial intelligence, and advanced analytics to modernize recruitment, utilization, and labor cost management. For employers, Prolucent drives greater applicant volume and conversion, manages contingent labor and internal flexible labor pools, and provides real-time data on utilization and costs. For healthcare workers, the company operates an integrated jobs marketplace with tools to manage careers and simplify applications. Prolucent annually promotes more than four million open positions from 30,000 healthcare employers and has over 500,000 clinicians registered on the Liquid Compass platform. The company plans to expand its sales, marketing, and client services teams and broaden product capabilities using the new capital.